Beta Drugs P/B Ratio
Beta Drugs P/B ratio. Beta Drugs (BETA) P/B ratio is 4.55 (High), book value per share ₹245.00 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse BETA financial statements for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BETA P/B Ratio — Valuation Insights & Book Value Analysis
Beta Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 4.55 (High). Read BETA dividend yield for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 4.55, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 39.6% below historical average
- Trading at premium to sector average PB of -0.3
Beta Drugs P/B Ratio Historical Trend
BETA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see BETA screener.
BETA Historical P/B Ratio — Book Value Per Share & Year-End Price
Beta Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 7.2 | ₹245.0 | ₹1764.20 | ₹245 | High |
| 2025 | 7.86 | ₹197.0 | ₹1549.10 | ₹197 | High |
BETA vs Healthcare Peers — P/B Ratio Comparison
Beta Drugs P/B 4.55 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |